Katerina Kotlabova (Ilona Hromadnikova, Ilona Hromadníková)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

International journal of molecular sciences

Biomedicines

Journal of personalized medicine

Journal of clinical medicine

Charles University, Third Faculty of Medicine

Charles University, First Faculty of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charles University, Third Faculty of Medicine

Czechia

prof. :: Department of Molecular Biology and Cell Pathology

Education History

Charles University, First Faculty of Medicine Oct 01 1993 - Sep 30 2000

Czechia

PHD :: Department of Biology and Cell Pathology

Charles University, Faculty of Science Sep 01 1988 - Sep 30 1993

Czechia

MSC :: Biochemistry

Publications

Katerina Kotlabova
Special Issue of Pathogenesis of Pregnancy-Related Complications, 2023. International journal of molecular sciences 25 (5) (2024)
Katerina Kotlabova
Special Issue of Pathogenesis of Pregnancy-Related Complications, 2023. International journal of molecular sciences 25 (5) (2024)
Veronika Viktoria Matraszek, Hynek Heřman, Katerina Kotlabova
The relevance of antiphospholipid antibodies in obstetrics. Ceska gynekologie 89 (3) (2024)
Katerina Kotlabova
Special Issue of Pathogenesis of Pregnancy-Related Complications, 2023. International journal of molecular sciences 25 (5) (2024)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for Miscarriage or Stillbirth-Prediction Model Based on MicroRNA Biomarkers. International journal of molecular sciences 24 (12) (2023)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for HELLP Syndrome-Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics. International journal of molecular sciences 24 (6) (2023)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for HELLP Syndrome-Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics. International journal of molecular sciences 24 (6) (2023)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for Miscarriage or Stillbirth-Prediction Model Based on MicroRNA Biomarkers. International journal of molecular sciences 24 (12) (2023)
Katerina Kotlabova
Pathogenesis of Pregnancy-Related Complications. International journal of molecular sciences 24 (6) (2023)
Katerina Kotlabova
Pathogenesis of Pregnancy-Related Complications. International journal of molecular sciences 24 (6) (2023)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for HELLP Syndrome-Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics. International journal of molecular sciences 24 (6) (2023)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for Miscarriage or Stillbirth-Prediction Model Based on MicroRNA Biomarkers. International journal of molecular sciences 24 (12) (2023)
Katerina Kotlabova
Pathogenesis of Pregnancy-Related Complications. International journal of molecular sciences 24 (6) (2023)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers. International journal of molecular sciences 23 (7) (2022)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers. Biomedicines 10 (3) (2022)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction. Biomedicines 10 (2) (2022)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
Novel First-Trimester Prediction Model for Any Type of Preterm Birth Occurring before 37 Gestational Weeks in the Absence of Other Pregnancy-Related Complications Based on Cardiovascular Disease-Associated MicroRNAs and Basic Maternal Clinical Characteristics. Biomedicines 10 (10) (2022)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications. International journal of molecular sciences 23 (18) (2022)
Katerina Kotlabova
Pathogenesis of Pregnancy-Related Complications 1.0 and 2.0. International journal of molecular sciences 23 (6) (2022)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
Association Analysis in Young and Middle-Aged Mothers-Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings. Journal of personalized medicine 11 (1) (2021)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta
A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications. International journal of molecular sciences 22 (8) (2021)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta, Jan Sirc
Postnatal Expression Profile of MicroRNAs Associated with Cardiovascular Diseases in 3- to 11-Year-Old Preterm-Born Children. Biomedicines 9 (7) (2021)
Katerina Kotlabova, Katerina Kotlabova, Lenka Dvorakova, Ladislav Krofta, Jan Sirc
Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus-One of Several Possible Reasons for an Increased Cardiovascular Risk. Cells 9 (6) (2020)
Katerina Kotlabova, Katerina Kotlabova, Ladislav Krofta, Jan Sirc
Association Analysis in Children Born from Normal and Complicated Pregnancies-Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects. International journal of molecular sciences 21 (21) (2020)
Katerina Kotlabova, Katerina Kotlabova, Lenka Dvorakova, Ladislav Krofta
Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications. Journal of clinical medicine 8 (4) (2019)
Ilona Hromadnikova, Katerina Kotlabova, Lenka Dvorakova, Ladislav Krofta, Jan Sirc
Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications. International journal of molecular sciences 20 (3) (2019)
Katerina Kotlabova, Lenka Dvorakova, Katerina Kotlabova, Ladislav Krofta
The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs. International journal of molecular sciences 20 (12) (2019)
Lenka Dvorakova, Katarina Ivankova, Ladislav Krofta, Katerina Kotlabova
Expression profile of heat shock proteins in placental tissues of patients with preterm prelabor rupture of membranes and spontaneous preterm labor with intact membranes. American journal of reproductive immunology (New York, N.Y. : 1989) 78 (4) (2017)

Katerina Kotlabova.css-eqlu8i{font-size:small;padding-left:4px;} (Ilona Hromadnikova, Ilona Hromadníková)

Publication Activity (10 Years)

Top Topics

Top Venues

Katerina Kotlabova (Ilona Hromadnikova, Ilona Hromadníková)